688091.SHG Shanghai Yizhong Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
37.06 CNY
Close of Nov 5, 2026
33.68 66.20
Market cap
CNY 7.66B
P/E
109.0x
P/B
4.91x
ROE
5.1%
Dividend yield
0.00%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688091.SHG undervalued?

Graham number

The Graham number of Shanghai Yizhong Pharmaceutical Co Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Yizhong Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Shanghai Yizhong Pharmaceutical Co Ltd yet.

Shanghai Yizhong Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Yizhong Pharmaceutical Co Ltd

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the research and development of anti-tumor drugs and related products in China. The company offers paclitaxel polymer micelles for injection for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, and gynecological tumors. Shanghai Yizhong Pharmaceutical Co., Ltd. was founded in 2009 and is …

Full company profile